Accessibility Statement — Regenerative Medicine
Last reviewed:
Our Commitment
ExaVeyra Sciences is committed to ensuring digital accessibility for people with disabilities. We continually improve the user experience for everyone and apply relevant accessibility standards so that our website, telehealth platform, and partner portals are usable by the widest possible audience—including individuals who use assistive technologies such as screen readers, magnification software, voice recognition, or alternative input devices.
Conformance Level
We strive to meet WCAG 2.1 Level AA success criteria where practicable. WCAG 2.1 defines requirements for making web content more perceivable, operable, understandable, and robust. Our goal is to conform to these guidelines across all public-facing pages, including product information, science content, telehealth booking, and legal/regulatory pages.
Accessibility Features
ExaVeyra provides the following to support accessible use:
- Keyboard navigation: All interactive elements are reachable and operable via keyboard.
- Skip links: Skip to main content and bypass repetitive navigation.
- Semantic structure: Headings (H1–H6), landmarks (main, nav, footer), and ARIA roles where needed.
- Color contrast: Text meets WCAG AA contrast ratios (4.5:1 for normal text, 3:1 for large text).
- Accessibility widget: In-page controls for high contrast, font size, spacing, dyslexia-friendly font, reduced motion, and focus enhancement.
- Alternative text: Images include descriptive alt attributes; decorative images use empty alt.
- Forms: Labels, error messages linked via aria-describedby, and clear validation feedback.
Testing & Evaluation
We evaluate accessibility through:
- Manual testing: Keyboard-only navigation, screen reader use (NVDA, VoiceOver, JAWS), and high-contrast/zoom scenarios.
- Automated tools: Google Lighthouse, axe DevTools, and WAVE to surface common issues.
- Design review: Color contrast, focus indicators, and semantic markup checked during development.
Some content—including third-party widgets, embedded media, or legacy materials—may not fully meet Level AA. We address reported issues and update content as we improve the site.
Known Limitations
We are aware of the following limitations and are working to remedy them:
- Some PDF or downloadable documents may not be fully accessible.
- Third-party chat or analytics scripts may introduce barriers.
- Video content may lack closed captions; we add captions where feasible.
Feedback & Assistance
If you encounter an accessibility barrier or need assistance using our website or services, please contact us:
- Contact page — general inquiries and feedback.
- Email — use the address listed on our contact page for written feedback.
We aim to acknowledge accessibility feedback within 2 business days and provide a substantive response within 10 business days. When possible, we will describe the steps we are taking to address the issue.
Alternative Formats
If you need information in an alternative format (e.g., large print, plain language, or braille-ready file), please contact us. We will work with you to provide the requested format where feasible.
Updates
This accessibility statement is reviewed periodically. We will update it as we improve our site and adopt new standards. The last review date is indicated at the top of this page.